Simone Lisa Böll

2PUBLICATIONS
2CO-AUTHORS
Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Nov 13, 2025
Topical Ruxolitinib and Delgocitinib Versus Systemic JAK Inhibitors: A Comparative Safety Review.

Simone Lisa Böll, Seyed Morteza Seyed Jafari, Curdin Conrad

Pageof 1